Recent Security Class Actions

Inari Medical Inc. Common Stock (NASDAQ: NARI)

Company Name:Inari Medical Inc. Common Stock
Stock Symbol:NASDAQ: NARI
Class Period Start:02/24/2022
Class Period End (inclusive):02/28/2024
Filing Deadline:07/12/2024

According to the Complaint, Inari Medical, Inc. is a medical device company that specializes in developing, manufacturing and commercializing catheter-based technologies for treating venous thromboembolism ("VTE"), a condition that occurs when a blood clot forms in a vein, usually in the lower leg, thigh, or pelvis.

The Complaint alleges that during the Class Period, Defendants consistently touted Inari's "record revenue," purportedly driven by "the strength in our core VTE business" while failing to disclose that a significant portion of its expenses were used to compensate medical professionals improperly for using Inari's products. The Complaint further alleges that the Company had been unlawfully compensating health care professionals in violation of the federal Anti-Kickback Statute and Civil False Claims Act and had misled investors regarding business expenses in order to conceal their illicit conduct.